COVID-19 pandemic: challenges ahead
Abstract Since December 2019, health systems worldwide have faced the pandemic caused by the new severe acute respiratory syndrome coronavirus 2. The pandemic began in China and has spread throughout the world. This new coronavirus has a high transmission capacity and elevated lethality in people over 60 years old and in those with risk factors (obesity, diabetes, and systemic arterial hypertension); those characteristics have a different proportion in each country. At present, there is no specific, effective, and safe treatment to treat this virus. In this review, an analysis is made on the differences in epidemiological aspects of the disease and its presentation in pediatric patients; the poorly-based recommendation for using an empirical combination of antimalarials plus antimicrobials as antiviral treatment; the indication of intravenous steroids; and the possible influence of antihypertensive drugs on the course of the disease.
Main Authors: | Márquez-González,Horacio, Miranda-Novales,María G., Solórzano-Santos,Fortino, Klunder-Klunder,Miguel, Garduño-Espinoza,Juan, Méndez-Galván,Jorge F. |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez
2020
|
Online Access: | http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462020000500242 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival in pediatric patients with cancer during the COVID-19 pandemic: scoping systematic review
by: Dorantes-Acosta,Elisa, et al.
Published: (2020) -
Measles outbreak during the COVID-19 pandemic in Mexico
by: Solórzano-Santos,Fortino, et al.
Published: (2020) -
COVID-19 pandemic: a different behavior in children
by: Muñoz-Hernández,Onofre, et al.
Published: (2020) -
Descartar la primera medición y considerar el promedio de tres mediciones subsiguientes, refleja cifras más estables de presión arterial en los niños
by: Klünder-Klünder,Miguel, et al.
Published: (2013) -
Anticuerpos contra SARS-CoV-2 en personal de investigación con infección asintomática en la etapa prevacunal
by: Solórzano-Santos,Fortino, et al.
Published: (2023)